Cite
APA Citation
Moehrle, J. J., Duparc, S., Siethoff, C., van, P. L. M., Craft, J. C., Arbe‐Barnes, S., Charman, S. A., Gutierrez, M., Wittlin, S., & Vennerstrom, J. L. (n.d.). first‐in‐man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials. British journal of clinical pharmacology, 75, 535–548. http://access.bl.uk/ark:/81055/vdc_100024470308.0x000004